{"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.068","statisticalComment":"Stratified Log Rank test adjusting for the stratification factor (Hepatocellular carcinoma versus liver metastases)","statisticalMethod":"Log Rank"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.12","upperLimit":"66.63","value":"51.18"},{"groupId":"OG001","lowerLimit":"17.46","upperLimit":"49.42","value":"32.99"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"33"}],"units":"Participants"}],"description":"Estimated by Kaplan-Meier method for overall survival defined as time from randomization to death from any cause.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients receive a radiation therapy with the use of 8 Gy in one fraction to the whole (or near-whole) liver together with the best supportive care.","id":"OG000","title":"Radiotherapy Combined With Best Supportive Care"},{"description":"Patients receive only the best supportive care.","id":"OG001","title":"Best Supportive Care Alone"}],"paramType":"NUMBER","populationDescription":"All patients randomized","reportingStatus":"POSTED","timeFrame":"90 days","title":"Proportion of Patients Alive at Day 90.","type":"SECONDARY","unitOfMeasure":"percentage of alive at 90 days"}